跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUPALL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RUPALL
Authorized
STANDARD
RUPALL
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
53b78d7452952b66
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
53b78d7452952b66
Drug Approval Canada Name
RUPALL
Product Name
RUPALL
Status
Marketed
Status Date
2023-02-02
Original Market Date
2017-01-20
Din
02456478
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
04:08.00
Atc Original
R06AX28 RUPATADINE
Atc Name
r 06 ax 28
Aig Number
0158310001
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
RUPATADINE (RUPATADINE FUMARATE)
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
53b78d7452952b66
Type
Standard
Back to Health Canada Approvals